Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dosing for recovery and adverse events in laparoscopic cholecystectomy
ChiCTR1900024801Phase 4Recruiting
- Sponsor
- North Sichuan Medical College
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in cholelithiasis and gallbladder disease (4 arms), sponsored by North Sichuan Medical College. Primary endpoints: Degree of cough during recovery, Sedation-Agitation Scale and 3 more. Started Jul 2019; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
cholelithiasisgallbladder disease
Beyond the preview
Go deeper on ChiCTR1900024801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024801.